Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours Β· Estimated delivery Aug 31 - Sep 5
I anyways use Fast&Up and personally like the brand, but if the study was also done on 10 people who had similar weight issues and maintained similar routine, it would have drawn better comparision.
A new 2026 study clarifies the muscle loss issue
Cardouat G, Duparc T, Fried S, Perret B, Najib S, Martinez LO
Key Research Attributes Highly stable dual GIP and GLP-1 receptor agonist Studied extensively in metabolic, obesity, and endocrine signaling research Investigated for pivotal roles in glucose regulation and insulin response models Explored deeply in appetite signaling, satiety, and systemic energy balance pathways Premium lyophilized format for maximum precision, stability, and reliability Intended strictly for in-vitro and controlled laboratory research use This dual-incretin mechanism continues to draw significant interest within the global scientific community
If a vial was frozen, left in heat, or exposed to extreme temperature swings, assume potency is reduced and contact your pharmacy before using it
The Competitor Landscape: Eli Lilly and Company is also playing aggressively, having partnered with Cipla for its weight-loss drug Mounjaro, which has already clocked an impressive 713 crore in cumulative sales since its launch in March of last year
US$ 28.09
US$ 26.31
US$ 24.58
US$ 23.79
